Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cancer patients face a hidden Second-Stroke threat, and 24 hospitals are mapping it

NCT ID NCT07819526

Knowledge-focused Sponsor: Osaka University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 21, 2026 · Updated 2 times

Summary

Researchers at 24 hospitals in Japan are following 500 people who had an acute ischemic stroke while also living with active cancer. The study measures how often a second stroke occurs within three months and which clinical factors, such as cancer type, stroke features, and test results, may be linked to recurrence. Participants receive standard care from their own doctors; researchers only collect information and do not assign any treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers learn which factors predict a second stroke in people with cancer, doctors could one day target monitoring and prevention more precisely for this group.
What could go wrong
This is an observational study, so it can only show patterns and associations, not cause and effect. The findings may not apply to patients outside Japan or to cancers not represented in the group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Mar 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of participants with acute ischemic stroke and active cancer who receive medical care at participating hospitals in Japan. Eligible participants will be enrolled prospectively during the study enrollment period.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Acute ischemic stroke diagnosed within 7 days after symptom onset or the time last known well. 2. Active cancer at the time of the index stroke, as defined below. Exclusion Criteria: 1. The patient or a legally acceptable representative indicates that the patient does not wish to participate. 2. The investigator considers enrolment inappropriate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Active cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer ischemic stroke neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Active cancer Acute ichemic stroke Acute ischemic stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Univeristy of Osaka

    RECRUITING

    Suita, Osaka, 565-0871, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.